TY - JOUR
T1 - Understanding the alphaviruses
T2 - Recent research on important emerging pathogens and progress towards their control
AU - Gould, E. A.
AU - Coutard, B.
AU - Malet, H.
AU - Morin, B.
AU - Jamal, S.
AU - Weaver, S.
AU - Gorbalenya, A.
AU - Moureau, G.
AU - Baronti, C.
AU - Delogu, I.
AU - Forrester, N.
AU - Khasnatinov, M.
AU - Gritsun, T.
AU - de Lamballerie, X.
AU - Canard, B.
N1 - Funding Information:
The work reported in this review was supported under the project entitled VIZIER (Comparative Structural Genomics of Viral Enzymes Involved in Replication)—Contract number (2004-511960). Professor Scott Weaver's alphavirus research was supported by National Institute of Health grants U54-AI057156, R01-AI071192 and R01-AI069145.
PY - 2010/8
Y1 - 2010/8
N2 - The alphaviruses were amongst the first arboviruses to be isolated, characterized and assigned a taxonomic status. They are globally very widespread, infecting a large variety of terrestrial animals, insects and even fish, and circulate both in the sylvatic and urban/peri-urban environment, causing considerable human morbidity and mortality. Nevertheless, despite their obvious importance as pathogens, there are currently no effective antiviral drugs with which to treat humans or animals infected by any of these viruses. The EU-supported project-VIZIER (Comparative Structural Genomics of Viral Enzymes Involved in Replication, FP6 Project: 2004-511960) was instigated with an ultimate view of contributing to the development of antiviral therapies for RNA viruses, including the alphaviruses [Coutard, B., Gorbalenya, A.E., Snijder, E.J., Leontovich, A.M., Poupon, A., De Lamballerie, X., Charrel, R., Gould, E.A., Gunther, S., Norder, H., Klempa, B., Bourhy, H., Rohayemj, J., L'hermite, E., Nordlund, P., Stuart, D.I., Owens, R.J., Grimes, J.M., Tuckerm, P.A., Bolognesi, M., Mattevi, A., Coll, M., Jones, T.A., Åqvist, J., Unger, T., Hilgenfeld, R., Bricogne, G., Neyts, J., La Colla, P., Puerstinger, G., Gonzalez, J.P., Leroy, E., Cambillau, C., Romette, J.L., Canard, B., 2008. The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res. 78, 37-46]. This review highlights some of the major features of alphaviruses that have been investigated during recent years. After describing their classification, epidemiology and evolutionary history and the expanding geographic distribution of Chikungunya virus, we review progress in understanding the structure and function of alphavirus replicative enzymes achieved under the VIZIER programme and the development of new disease control strategies.
AB - The alphaviruses were amongst the first arboviruses to be isolated, characterized and assigned a taxonomic status. They are globally very widespread, infecting a large variety of terrestrial animals, insects and even fish, and circulate both in the sylvatic and urban/peri-urban environment, causing considerable human morbidity and mortality. Nevertheless, despite their obvious importance as pathogens, there are currently no effective antiviral drugs with which to treat humans or animals infected by any of these viruses. The EU-supported project-VIZIER (Comparative Structural Genomics of Viral Enzymes Involved in Replication, FP6 Project: 2004-511960) was instigated with an ultimate view of contributing to the development of antiviral therapies for RNA viruses, including the alphaviruses [Coutard, B., Gorbalenya, A.E., Snijder, E.J., Leontovich, A.M., Poupon, A., De Lamballerie, X., Charrel, R., Gould, E.A., Gunther, S., Norder, H., Klempa, B., Bourhy, H., Rohayemj, J., L'hermite, E., Nordlund, P., Stuart, D.I., Owens, R.J., Grimes, J.M., Tuckerm, P.A., Bolognesi, M., Mattevi, A., Coll, M., Jones, T.A., Åqvist, J., Unger, T., Hilgenfeld, R., Bricogne, G., Neyts, J., La Colla, P., Puerstinger, G., Gonzalez, J.P., Leroy, E., Cambillau, C., Romette, J.L., Canard, B., 2008. The VIZIER project: preparedness against pathogenic RNA viruses. Antiviral Res. 78, 37-46]. This review highlights some of the major features of alphaviruses that have been investigated during recent years. After describing their classification, epidemiology and evolutionary history and the expanding geographic distribution of Chikungunya virus, we review progress in understanding the structure and function of alphavirus replicative enzymes achieved under the VIZIER programme and the development of new disease control strategies.
KW - Alphavirus
KW - Antivirals
KW - Biogeography
KW - Classification
KW - Evolution
KW - Genomics
KW - Replicative enzymes
KW - Structure/function studies
KW - VIZIER
UR - http://www.scopus.com/inward/record.url?scp=77954952122&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954952122&partnerID=8YFLogxK
U2 - 10.1016/j.antiviral.2009.07.007
DO - 10.1016/j.antiviral.2009.07.007
M3 - Review article
C2 - 19616028
AN - SCOPUS:77954952122
SN - 0166-3542
VL - 87
SP - 111
EP - 124
JO - Antiviral research
JF - Antiviral research
IS - 2
ER -